Statement | 24 April 2013 Intellectual property and trade Vaccines MSF statement on GAVI's response to 'Dear GAVI' campaign
Statement | 18 April 2013 Vaccines MSF responds to Decade of Vaccines supplement launch in the journal VACCINES
Statement Statement | 04 March 2013 Intellectual property and trade India India upholds compulsory licence on cancer drug in Bayer case appeal
Statement | 16 January 2013 HIV/AIDS MSF addresses study by Massachusetts General Hospital on implications of switching from branded to generic antiretrovirals for HIV 4 min
Statement | 22 November 2012 Intellectual property and trade Why Roche can decrease its prices and why it has a moral obligation to do so
Statement | 17 October 2012 Tuberculosis MSF response to release of new WHO report on tuberculosis, which reveals growing drug-resistant TB emergency
Statement | 17 September 2012 Intellectual property and trade India MSF statement on India's dismissal of Bayer's request for a stay on compulsory licence
